RE:RE:Bisha got us here but there will come a time to monetize it. I agree with most of what you say incube. As far as the $4.00 per share US price. I said it could easily go there if they sell Bisha. I did not say that it would be an adequate buyout for the entire company. I can see NSU at $5 to $6 US in the next 12 to 18 months with or without Bisha. By the way they would not have to cut the dividend if they sold Bisha. They could even increase it a bit as Timok would be coming on line in a couple of years. That upper zone supergene is so high grade that it will be a cash generator almost from the start. They spend $48 million a year on dividends so two years would be $96 million. Not that much when you would probably have close to $1 billion in cash and Timok to develope. As I said before I give NSU management the benefit of the doubt. They know Bisha's value and its future potential more than we do.